Ghoshal Kaushik
Known title: President, SaaS BusinessCIK: 0001881922
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ResMed Q4 2026 Earnings Call Transcript Released. ResMed has released the transcript for its Q4 2026 earnings call, providing investors with detailed insights into the company's recent performance. This follows a quarterly earnings preview and places the stock within a broader market forecast for the mHealth sector. The release offers a factual record of management's comments on financial results and strategic direction.
Transaction History
| OMCL | ▲ Buy | Grant | 4,603 | $0 | 6/1/2026 | View on chart |
| OMCL | ▲ Buy | Grant | 6,401 | $0 | 6/1/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 169 | $25K | 3/10/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 105 | $22K | 3/10/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 3,589 | $525K | 3/10/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 5,882 | $1.2M | 3/10/2025 | View on chart |
| RMD | ▼ Sell | Open Market | 9,745 | $2.3M | 3/10/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 367 | $78K | 3/3/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 3,506 | $513K | 3/3/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 514 | $75K | 3/3/2025 | View on chart |
| RMD | ▲ Buy | Option Exercise | 4,726 | $1.0M | 3/3/2025 | View on chart |
| RMD | ▼ Sell | Open Market | 367 | $86K | 3/3/2025 | View on chart |
| RMD | ▼ Sell | Open Market | 3,506 | $825K | 3/3/2025 | View on chart |
| RMD | ▼ Sell | Open Market | 514 | $121K | 3/3/2025 | View on chart |
| RMD | ▼ Sell | Open Market | 4,726 | $1.1M | 3/3/2025 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 603 | $152K | 11/11/2024 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 446 | $112K | 11/11/2024 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 1,418 | $358K | 11/11/2024 | View on chart |
| RMD | ▼ Sell | Other | 9,628 | $0 | 10/30/2024 | View on chart |
| RMD | ▼ Sell | Other | 9,628 | $0 | 10/30/2024 | View on chart |
| RMD | ▲ Buy | Option Exercise | 4,260 | $433K | 10/11/2024 | View on chart |
| RMD | ▼ Sell | Open Market | 4,260 | $1.0M | 10/11/2024 | View on chart |
| RMD | ▲ Buy | Option Exercise | 5,000 | $508K | 9/12/2024 | View on chart |
| RMD | ▼ Sell | Open Market | 5,000 | $1.3M | 9/12/2024 | View on chart |
| RMD | ▲ Buy | Grant | 841 | $0 | 8/15/2024 | View on chart |
| RMD | ▲ Buy | Grant | 7,915 | $0 | 8/15/2024 | View on chart |
| RMD | ▲ Buy | Option Exercise | 2,086 | $200K | 8/12/2024 | View on chart |
| RMD | ▲ Buy | Option Exercise | 6,877 | $659K | 8/12/2024 | View on chart |
| RMD | ▲ Buy | Option Exercise | 1,037 | $105K | 8/12/2024 | View on chart |
| RMD | ▼ Sell | Open Market | 10,000 | $2.2M | 8/12/2024 | View on chart |
| OMCL | ▲ Buy | Grant | 5,717 | $0 | 5/21/2024 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 367 | $55K | 11/20/2023 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 591 | $85K | 11/13/2023 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 436 | $63K | 11/13/2023 | View on chart |
| RMD | ▲ Buy | Grant | 2,486 | $0 | 8/17/2023 | View on chart |
| OMCL | ▲ Buy | Grant | 2,402 | $0 | 7/26/2023 | View on chart |
| RMD | ▼ Sell | Open Market | 500 | $110K | 7/13/2023 | View on chart |
| RMD | ▼ Sell | Open Market | 500 | $110K | 6/2/2023 | View on chart |
| RMD | ▼ Sell | Open Market | 500 | $120K | 5/1/2023 | View on chart |
| RMD | ▼ Sell | Open Market | 2,000 | $460K | 4/24/2023 | View on chart |
| RMD | ▼ Sell | Open Market | 500 | $110K | 4/3/2023 | View on chart |
| RMD | ▼ Sell | Open Market | 1,000 | $220K | 3/3/2023 | View on chart |
| RMD | ▲ Buy | Grant | 7,288 | $0 | 11/23/2022 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 4,318 | $969K | 11/23/2022 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 307 | $69K | 11/11/2022 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 591 | $133K | 11/11/2022 | View on chart |
| RMD | ▲ Buy | Grant | 3,366 | $0 | 8/18/2022 | View on chart |
| RMD | ▲ Buy | Grant | 697 | $0 | 11/18/2021 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 5,112 | $1.3M | 11/17/2021 | View on chart |
| RMD | ▲ Buy | Grant | 9,162 | $2.3M | 11/16/2021 | View on chart |
| RMD | ▼ Sell | Tax Withholding | 976 | $253K | 11/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Omnicell Set to Release Q3 2026 Results; Guidance Update
Omnicell will publish its third‑quarter 2026 earnings on Oct. 29, 2026. Analysts noted the company beat revenue expectations but issued weaker EBITDA guidance, which may affect the bullish outlook. The stock is currently near its 12‑touch support level of $42.89 and trades below the average analyst target of $57.86.
Omnicell Set to Release Q3 2026 Results; Guidance Update. Omnicell will publish its third‑quarter 2026 earnings on Oct. 29, 2026. Analysts noted the company beat revenue expectations but issued weaker EBITDA guidance, which may affect the bullish outlook. The stock is currently near its 12‑touch support level of $42.89 and trades below the average analyst target of $57.86.